Mitral valve periprosthetic leakage: Anatomical observations in 135 patients from a multicentre study

Giuseppe De Cicco1, Claudio Russo, Antonella Moreo

  • 1Cardiac Surgery Unit, Civic Hospital, Brescia, Italy. giudeci@libero.it

Abstract

Insights

Periprosthetic leakage (PPL) after mitral valve replacement (MVR) occurs more often in specific mitral valve annulus (MVA) regions. Understanding these anatomical locations can help prevent reoperations and improve patient outcomes.

Area of Science:

  • Cardiovascular Surgery
  • Cardiac Surgery
  • Medical Device Research

Background:

  • Prosthetic valve dysfunction following mitral valve replacement (MVR) often necessitates reoperation.
  • Periprosthetic leakage (PPL) is a frequent cause of reoperation after MVR.
  • Limited research has explored the relationship between anatomical factors and PPL, especially concerning bacterial involvement.

Purpose of the Study:

  • To investigate the specific anatomical locations of periprosthetic leakage (PPL) after mitral valve replacement (MVR).
  • To identify potential anatomical correlations with PPL occurrence in patients requiring reoperation.

Main Methods:

  • A multicentre retrospective study included 135 patients who underwent reoperation for PPL after MVR between 1985 and 2005.
  • The mitral valve annulus (MVA) was systematically analyzed in a clockwise manner to pinpoint leakage sites.

Main Results:

  • Hospital mortality was 3.7%.
  • PPL occurred more frequently in the antero-lateral (hour 5-6) and postero-medial (hour 10-11) segments of the MVA.
  • The risk of leakage was 2.8 times higher at hour 5-6 and 2.0 times higher at hour 10-11 compared to other MVA areas.

Conclusions:

  • Periprosthetic leakage (PPL) after MVR is more prevalent in the antero-lateral and postero-medial segments of the mitral valve annulus (MVA).
  • These findings suggest that specific anatomical and functional characteristics of these MVA regions may predispose to PPL.
  • Targeted attention to these sectors during suture placement in MVR may help reduce the incidence of PPL.

Related Concept Videos

Mitral Valve Prolapse I: Introduction01:27

Mitral Valve Prolapse I: Introduction

IntroductionThe mitral valve, one of the heart's four valves, regulates blood flow. These valves have flaps that open and close to direct blood properly through the heart and body. During each heartbeat, the flaps open for blood to pass through and seal shut to prevent backflow. Specifically, the mitral valve opens to allow blood flow from the heart's upper left chamber to the lower left chamber. It then closes securely as the lower left chamber contracts to pump blood to the body, preventing...
Mitral Regurgitation I: Introduction01:20

Mitral Regurgitation I: Introduction

Mitral regurgitation is characterized by the backward circulation of blood from the left ventricle to the left atrium during systole, a phase of the cardiac cycle when the heart contracts and pumps blood out of the chambers. This abnormal flow occurs primarily due to the dysfunction of the mitral valve or its supporting structures, which include the mitral leaflets, chordae tendineae, annulus, and papillary muscles.Etiology and Mechanisms:Primary Mitral Regurgitation: This type arises from...
Mitral Valve Prolapse II: Assessment and Management01:22

Mitral Valve Prolapse II: Assessment and Management

IntroductionA range of clinical features characterizes Mitral Valve Prolapse (MVP), but it is important to note that many individuals with MVP are asymptomatic and may remain so throughout their lives. For those who do exhibit symptoms, the following are the key clinical features:Palpitations: This is a common symptom where individuals feel an irregular or rapid heartbeat. Palpitations in MVP are often due to arrhythmias such as premature ventricular contractions or supraventricular tachycardia.
Mitral Regurgitation II: Clinical Features and Diagnostic Tests01:23

Mitral Regurgitation II: Clinical Features and Diagnostic Tests

Mitral regurgitation (MR) is a valvular heart disorder in which the mitral valve fails to close tightly, allowing blood to leak backward into the heart. Understanding the clinical manifestations, assessment, diagnostic findings, and medical management of MR is crucial to effectively managing affected patients.Clinical Manifestations of Mitral RegurgitationMitral regurgitation can be acute or chronic, each presenting differently and requiring different approaches:1. Acute Mitral...
Mitral Stenosis I: Introduction01:22

Mitral Stenosis I: Introduction

Mitral Valve Stenosis (MVS) is a heart condition where the mitral valve narrows, impeding blood circulation from the left atrium to the left ventricle. The etiology and pathophysiology of this condition are multifaceted, leading to a cascade of cardiovascular complications.Causes of Mitral Valve StenosisRheumatic Heart Disease: It is the main cause of mitral valve stenosis, particularly in developing nations. This condition arises from rheumatic fever, an inflammatory illness resulting from...
Mitral Stenosis III: Medical Management01:26

Mitral Stenosis III: Medical Management

Mitral stenosis, a condition marked by the narrowing of the mitral valve, necessitates an integrated approach for effective management. This approach includes preventative measures, medical therapy, and surgical interventions to reduce symptoms and prevent complications.PreventionPrevention of mitral stenosis primarily focuses on reducing the incidence of bacterial infections, particularly streptococcal infections, which can lead to rheumatic fever and subsequent valvular damage. Timely...